More Articles Back to Article
EU to implement BCS-based biowaiver guideline in July
The International Council for Harmonisation's M9 guideline on biopharmaceutics classification system-based biowaivers will take effect July 30, according to the European Medicines Agency. The 18-page guideline covers various topics, including which drugs are eligible for a BCS-based biowaiver and how drug solubility and permeability can be evaluated. Regulatory Focus (2/11)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!